Interview with the CEO of Regrow, one of the top companies recognized within the agriculture imagery category. For more information visit startupdealflow.com
Interview with the CEO of VIDA, one of the top companies recognized within the healthcare imagery category.
1:04: What does VIDA do?
1:35: What is the backstory of VIDA?
2:47: When would providers use VIDA?
4:58: Why are CT scans used for respiratory exams?
6:28: What did providers do without VIDA?
8:43: Can you share more details about your patent on visualizing lungs?
10:33: How did you build your platform’s functionality?
13:44: How much assistance does your AI solution provide?
17:41: Can you talk about your supporting services that you offer to your customers?
22:09: Are there limitations or risks using your platform?
25:37: How do you implement VIDA?
28:54: How do you manage long sales cycles?
30:50: How has the pandemic affected your company?
36:36: What is the future of healthcare imagery services?
39:16: Closing remarks
About VIDA: VIDA provides AI-powered chest CT analysis to profile/manage a patient with, or at-risk of, respiratory diseases. Their software automatically quantifies lung density and visualizes airways. They do this using a topographic MPR technique that samples/projects many non-overlapping airways onto a single image. This method delivers global airway information, at higher resolution, without losing context to the surrounding tissue. Their platform also provides per-procedural pat planning, intra-procedural guidance (virtual bronchoscopy), lung cancer resection (LCR) evaluations and lung volume analysis reports. Visit: vidalung.ai
Interview with the CEO of DiA Imaging Analysis, one of the top companies recognized within the healthcare imagery category.
1:06: What does DiA do?
3:24: What is the backstory behind DiA?
5:58: Why did you focus on ultrasound?
8:47: Are you providing software, hardware or both?
12:00: How did you build your AI solutions?
16:03: How far do you go with assisting providers?
20:53: How do you manage long sales cycles? How has the pandemic affected your company?
24:06: Closing remarks
About: DiA Imaging Analysis provides AI-powered cardiac ultrasound analysis solutions. Visit: https://www.dia-analysis.com/
Interview with the VP Marketing at Circle Cardiovascular Imaging, one of the top companies recognized within the healthcare imagery category.
1:10: What does Circle Cardiovascular Imaging do?
3:55: What’s the backstory of Circle Cardiovascular Imaging?
5:25: Most of your features revolve around quantifying heart structures - why is this important?
7:33: How did you build the functionality of your platform?
10:21: Is your platform making diagnosis?
12:15: Why is providing 3D models of the heart important?
14:57: Why is measuring exact blood flow from MR scans important?
17:29: What did providers do without your platform?
19:24: What does that workflow look like for providers?
22:36: What is your implementation process?
26:20: Are you making diagnosis?
29:15: Do providers prefer to have guided workflows or just data?
30:23: What do the new AI assist features do?
32:54: What does the AI assist tool look like to a provider?
35:13: How do providers physically interact with Circle Cardiovascular Imaging?
37:35: How do you manage long sales cycles?
40:09: How have you managed to grow internationally?
42:22: What deliverables resonate with your customers?
43:33: What is the business model? What is the market size for cardiovascular imagery?
47:35: How has the pandemic affected your company?
49:35: What is the future healthcare imagery services?
51:35: Closing remarks
Interview with Qidong Jia, Partner at CentreGold Capital, one of the top investors recognized within the healthcare industry.
1:03 Who is CentreGold Capital?
3:48 Why did you focus on a select few areas of healthcare?
7:22 Are you looking for moonshots or something practical as an early stage healthcare investor?
11:10 Do you focus on platform plays or tools for specific conditions?
16:20 Can you highlight some of your investments?
21:47 How do you know the right tool to manage a specific health issue?
27:03 Healthcare has long sales cycles - how does this shape your investment thesis?
31:22 How does the pandemic change your outlook on healthcare?
34:50 Are there any healthcare technology companies you’re excited about?
37:16 Highlighting unique features of Catalyst Health Ventures - portfolio development
39:24 Closing Remarks
About CentreGold Capital: CentreGold Capital invests in early-stage consumer marketplaces and digital health startups in North America and China. We back visionary entrepreneurs with innovative solutions to improve quality of life. Being sector-focused enables us to support our portfolio companies within an ecosystem. Visit: www.centregoldcap.com
Interview with the CEO of Arterys, one of the top companies recognized within the healthcare imagery category.
1:00: What does Arterys do?
8:58: What is the backstory of Arterys?
11:00: What imagery use case did you choose to start with?
12:11: Can you explain cardiovascular AI imagery features and how they change provider workflows?
16:53: How did you build this platform? Where did data come from? Are there limitations?
19:57: Can you explain chest CT AI imagery features?
23:51: How did you build this functionality for CT imagery analysis?
25:35: Can you explain your X-Ray AI assist?
29:17: Are there any other applications providers can do using your current tools?
31:22: Why are you expanding into multiple imagery verticals?
36:02: What is your relationship with the vendors in your marketplace?
38:32: How do you implement Arterys?
43:13: What level of assistance do you provide to radiologists?
45:55: Why do you have 7 FDA clearances?
47:30: How do you manage healthcare long sales cycles?
49:22: What deliverables resonate with your customers?
51:31: What is your business model?
53:00: What is the market size for imagery?
55:27: What is the future of imagery services?
57:43: How has the pandemic affected your company?
59:22: Closing Remarks
Interview with the Chief Medical Officer at SpringTide Ventures, one of the top investors recognized within the healthcare industry.
0:50 Who is Springtide Ventures?
2:07 What is your background?
4:40 What is AI healthcare investing?
7:12 Healthcare is so vast, how do you filter this industry?
11:11 Are you looking for moonshots or something practical as an early stage healthcare investor?
14:25 What do you see in healthcare most people don’t?
17:19 Can it be limiting to invest in healthcare?
18:40 Can you highlight some of your investments?
24:17 Healthcare has long sales cycles - how does this shape your investment thesis?
28:22 How do you know the right tool to manage a specific health issue?
31:54 Do you focus on platform plays or tools for specific conditions?
33:25 How does the pandemic change your outlook on healthcare?
38:11 Highlighting unique features of Springtide Ventures - portfolio development and sales network.
41:42 Closing Remarks
About SpringTide Ventures: SpringTide is a network of experienced healthcare founders, operators, and investors in the healthcare space. With over $350M in collective exits across 4 startup companies, our Managing Partners are driven to provide access and support for fellow entrepreneurs who are expanding access to quality healthcare. Visit: www.springtideinvestments.com
Interview with the CEO of Healint, one of the top companies recognized within the healthcare health management category.
0:55 What does Healint do?
2:23 What’s the background story of Healint?
6:52 Why did you focus on migraines first?
13:36 Why did you choose to focus on D2C?
19:53 What type of patients are using your platform?
25:32 How did you build your prediction models and treatment recommendations?
31:03 How are you able to detect upcoming attacks?
36:26 You’ve built a 10M patient registry, what’s its purpose?
41:26 Can you talk about some of the applications you’ve built off of your patient registry?
44:02 How do you plan to expand outside of Migraine?
47:23 What is the future of health management?
52:56 Closing remarks
About Healint: Healint provides a migraine and headache health tracker. Users can track/find patterns, participate in crowdsourced learnings, predict risks/anticipate attacks, find the best reliefs, view coaching plans, record sleep, generate attack reports and more. Visit: healint.com
About Top Startups Summit: The Top Startups Summit was created to recognize the top startups in a specific industries globally. We've spent months mapping industries, selecting the top companies and writing detailed reports on the best technologies. We have hosted many investor-only events to discuss industry trends. Now we're opening our work to the public. We will share the list of all the top startups per industry, a lengthy due diligence report and we'll invite the best founders & investors on stage to share unique insights you won't find anywhere else.... all for free. Visit: TopStartupsSummit.com
Interview with Amit Aysola, Managing Director at Wanxiang Healthcare Investments, one of the top investors recognized within the healthcare industry.
0:51 Who is Wanxiang Healthcare Investments?
3:36 What is your healthcare investment thesis?
7:10 Healthcare is so vast, how do you filter this industry?
11:07 Are you looking for moonshots or something practical as an early stage healthcare investor?
17:10 What do you see in healthcare most people don’t?
21:47 Can it be limiting to invest in healthcare?
24:00 Can you highlight some of your investments?
32:11 How do you know the right tool to manage a specific health issue?
34:43 Do you focus on platform plays or tools for specific conditions?
40:00 Healthcare has long sales cycles - how does this shape your investment thesis?
43:00 What is the business model that works for the health management category?
47:30 How does the pandemic change your outlook on healthcare?
51:00 Highlighting unique features of Wanxiang Healthcare Investments - very flexible.
54:40 Closing Remarks
About Wanxiang Healthcare Investments: Wanxiang Healthcare Investments is the venture capital arm of Wanxiang America Corporation. They invest in innovative, early to growth stage companies and target opportunities in Health IT. Visit: www.wanxianghealthcare.com
About Top Startups Summit: The Top Startups Summit was created to recognize the top startups in a specific industries globally. We've spent months mapping industries, selecting the top companies and writing detailed reports on the best technologies. We have hosted many investor-only events to discuss industry trends. Now we're opening our work to the public. We will share the list of all the top startups per industry, a lengthy due diligence report and we'll invite the best founders & investors on stage to share unique insights you won't find anywhere else.... all for free. Visit: TopStartupsSummit.com
Interview with the CEO of Sweetch, one of the top companies recognized within the healthcare health management category.
1:20 What does Sweetch do?
3:48 What is the backstory of Sweetch?
9:24 Why did you focus on chronic conditions?
13:09 How does Sweetch collect data and create personalized care plans?
23:55 What keeps patient engaged long term?
32:06 What is your business model?
36:47 How has the pandemic affected your company?
39:30 What is the future of chronic care management is going?
44:39 Closing Remarks
About Sweetch: Sweetch provides an AI-based digital personal intervention program for different chronic disease conditions including metabolic disease, cardiovascular and autoimmune. Sweetch's platform guides users to achieving their goals relating to weight, activity, healthy nutrition/habits, medication adherence, and treatment protocols. This platform automatically turns data points from a user's smartphone, connected devices and surveys, into personalized recommendations. These recommendations continuously adapt to the user's personal, environmental and behavioral preferences. They also provide a customized web-based management dashboard for providers to view patients data, it can predict chronic disease and engage users to keep them on track with their health goals. Visit: sweetch.com
Interview with Darshana Zaveri, Managing Partner at Catalyst Health Ventures, one of the top investors recognized within the healthcare industry.
0:50 Who is Catalyst Health Ventures?
2:19 What is the backstory of Catalyst Health Ventures?
4:09 What is your healthcare investment thesis?
9:28 Healthcare is so vast, how do you filter this industry?
13:14 Are you looking for moonshots or something practical as an early stage healthcare investor?
16:40 Understanding products that blend therapeutics and a mechanical solution.
20:20 What is your thoughts on digital therapeutics?
25:08 Can it be limiting to invest in healthcare?
27:29 Can you highlight some of your investments?
35:14 How do you know the right tool to manage a specific health issue?
39:35 What is the business model that works for the medical devices? Healthcare has long sales cycles - how does this shape your investment thesis?
44:30 How does the pandemic change your outlook on healthcare?
48:54 Highlighting unique features of Catalyst Health Ventures - portfolio development
52:27 Closing Remarks
About Catalyst Health Ventures: Catalyst Health Ventures (CHV) is a venture capital firm investing in disruptive solutions for global, unmet healthcare needs. CHV focuses on early-stage opportunities across medical devices, medical technology, diagnostics, digital health and life science tools. CHV portfolio companies provide strong clinical value propositions and cost savings across major markets including cancer, cardiovascular disease, metabolic disease, and women's health. Visit: catalysthealthventures.com
Interview with the CEO of Thryve, one of the top companies recognized within the healthcare genetics category.
1:05 What does Thryve do?
5:42 What is the backstory of Thryve?
8:17 Why did you focus on gut microbiome?
11:13 How do you sequence samples?
12:13 Is it difficult to manage samples?
14:48 What are you sequencing services looking for?
16:30 How did you collect data to be able to offer customize care?
21:20 Are you diagnosing patients or helping managing chronic conditions?
24:07 How often should you take a microbiome test?
25:34 What is the American Gut Project?
26:55 Why and how did you launch your own custom probiotics?
32:00 Are you concerned about customer behavior?
33:10 What is your business model?
36:26 Are there any risks or limitations you’re worried about?
37:40 How has the pandemic affected your company?
39:34 What is the future of genetic services?
43:40 Closing Remarks
About Thryve: Thryve provides consumer microbiome testing kits that analyze feces to target the good and bad bacteria in users' gut to treat the root cause of their symptoms. Visit: www.thryveinside.com
Interview with Cyril Philip, Principal at Providence Ventures, one of the top investors recognized within the healthcare industry.
1:08: Who is Providence Ventures?
4:20: Why did Providence decide to create their own venture capital arm?
7:26: Healthcare is so vast, how do you filter this industry?
11:00: You seem to focus on operational healthcare solutions, why?
14:54: Are you looking for moonshots or something practical as an early stage healthcare investor?
17:40: What do you see in healthcare most people don’t?
21:05: Can it be limiting to invest in healthcare?
25:00: Can you highlight some of your investments?
31:55: Do you focus on platform plays or tools for specific conditions?
35:15: Healthcare has long sales cycles - how does this shape your investment thesis?
39:00: How does the pandemic change your outlook on healthcare?
49:11: Are there any healthcare technology companies you’re excited about?
53:20: Highlighting unique features of Providence Ventures - synergy team, portfolio development strategy.
57:08: Closing Remarks
About Providence Ventures: Providence Ventures, founded in 2014, manages $300 million in venture capital funds on behalf of Providence St. Joseph Health (PSJH), one of the largest integrated health systems in the US. Providence Ventures' mission is to achieve venture and growth equity class returns through direct investments in innovative healthcare companies that improve health outcomes, lower costs, and enhance the experience of our patients and caregivers. Providence Ventures offers investment capital, combined with health system expertise, to companies addressing existing and emerging pain points in healthcare. Providence Ventures partners with our portfolio companies to refine existing solutions, while expanding their adoption within and beyond our health system. Visit: www.providenceventures.org
Interview with the CEO of Nalagenetics, one of the top companies recognized within the healthcare genetics category.
0:56 What does Nalagenetics do?
3:22 What is the backstory of Nalagenetics?
7:06 Why did you want to focus on medication adherence for genetics?
11:03 How are you sequencing samples?
13:20 Do you provide sampling kits?
16:34 What are the samples you collect and is it difficult to manage them?
19:30 Can your platform use genetic data sequenced from other sequencing services?
20:40 Can you explain what genes you’re analyzing against common drugs?
29:49 Why is it important for providers to use Nalagenetics?
34:30 Who initiates these genetic tests?
36:37 Do you overlap with clinical trials?
38:56 Did you want to highlight any of your software features?
43:20 What is the future of genetic services?
47:01 Closing Remarks
About Nalagenetics: Nalagenetics provides end-to-end support service that covers the provision of genetic tests all the way to the interpretation of the patient’s test results and generation of actionable drug-gene reports. Their tests are designed to analyze the five genes and 30+ most commonly prescribed drugs in an outpatient setting. These tests predict the patient’s drug response based on their genetic makeup. These services are delivered through web and mobile platforms where patients can talk to their physicians, as well as ask their genetic counselor and pharmacist regarding their test result. Visit: www.nalagenetics.com
Interview with the CEO of DocDoc, one of the top companies recognized within the healthcare telemedicine category.
1:33 What does DocDoc do?
5:27 What is the backstory of DocDoc?
12:13 How do you collect data on providers? And what do patients input to find providers?
19:28 What is the benefit to providers by working with DocDoc?
21:30 How do patients interface with DocDoc?
24:24 Does your telemedicine economics scale?
27:09 What are the patient triggers to get patients to use DocDoc?
31:44 What is the benefit to payers by working with DocDoc?
35:08 Telemedicine seems very limiting for care, can you explain how you move past the simplest forms of care?
40:11 What is your business model?
48:03 Do payers want telemedicine tools because they are cool or because they offer value?
53:54 How did you get a really high net promoter score?
55:30 How do you manage long sales cycles?
1:01:19 How have you been able to expand to be an international company?
1:04:05 What are the deliverables you pitch to your customers?
1:05:13 What is the market size for DocDoc?
1:08:25 How has the pandemic affected your company?
1:11:47 What is the future of telemedicine?
1:13:20 Closing Remarks
Interview with the Executive Chairman of Medically Home, one of the top companies recognized within the healthcare telemedicine category.
1:09 What does Medically Home do?
3:28 What is the backstory of Medically Home?
16:45 What type of patients are you focused on caring for?
20:05 How do patients decide to use Medically Home?
21:26 Are you becoming a provider?
23:05 What devices are you using in home and where did you get them?
28:02 How do you manage providers that need to go to patients homes?
32:19 Are there any risks taking care of patients at home?
35:37 What is the implementation process of Medically Home?
40:01 How did you build yourself into provider workflows?
42:18 What deliverables resonate with providers?
48:27 What is your business model & market size?
53:55 How has the pandemic affected your company?
1:01:27 What is the future of telemedicine?
1:08:49 Closing Remarks
About Medically Home: Medically Home telemedicine solutions for high-acuity patients at home. They set up an at home hospital that include vitals monitoring, video/audio calling tools and emergency response tools. Providers can check-in with patients over video and stop by the house for care, medication support, lab services, and administer other services. They also provide a dashboard for providers to manage patients care plans, staff nurses and more. Visit: www.medicallyhome.com
About Top Startups Summit: The Top Startups Summit was created to recognize the top startups in a specific industries globally. We've spent months mapping industries, selecting the top companies and writing detailed reports on the best technologies. We have hosted many investor-only events to discuss industry trends. Now we're opening our work to the public. We will share the list of all the top startups per industry, a lengthy due diligence report and we'll invite the best founders & investors on stage to share unique insights you won't find anywhere else.... all for free. Visit: TopStartupsSummit.com
About MDI Ventures: MDI Ventures is a US$800 million+ multi-fund venture capital arm of Indonesia's largest telecom company Telkom Group. It is one of the best-performing tech investment funds in Asia. Visit: mdi.vc
Interview with the CEO of Reveleer, one of the top companies recognized within the healthcare platform category.
0:45: What does Reveleer do?
4:32: How does Reveleer actually work and collect data?
8:57: Can you explain some of your offerings like quality reviews, gap closure, risk adjustment audit, etc?
11:35: What is the traditional process of quality review and risk adjustment?
14:40: Why is risk adjustment & quality review processes broken?
17:30: Is it difficult to work directly with providers to collect data?
18:35: What is the primary method of collecting data today?
19:50: How did you built out your functionality of scaling data collection and analysis?
23:25: Can you expand upon your analytics features?
27:10: What does it mean for health plans to target specific patients for auditing & quality review?
30:00: Are there common mistakes providers make that Reveleer catches?
32:18: What type of health plans do you work with?
33:39: What is your implementation process?
34:56: What is your business model?
36:30: Do you face long sales cycles?
38:34: What deliverables really resonate with your customer base?
42:50: What is the future risk adjustment and quality reviews for health plans?
46:12: Closing Remarks
About Reveleer: Reveleer’s platform finds medical records for the right members, identifies missed diagnoses and accurately reports/codes those missed diagnoses to help providers take full advantage of insurance plans. They also offer a set of coding and analytics options that include coding diagnoses other than the ones supporting HCCs, logic-driven member suspect identification data comparisons or the use of identified diagnoses as a baseline. They also provide a built-in audit defense tool which eliminates uncertainty during an audit. Visit: www.reveleer.com
About Top Startups Summit: The Top Startups Summit was created to recognize the top startups in a specific industries globally. We've spent months mapping industries, selecting the top companies and writing detailed reports on the best technologies. We have hosted many investor-only events to discuss industry trends. Now we're opening our work to the public. We will share the list of all the top startups per industry, a lengthy due diligence report and we'll invite the best founders & investors on stage to share unique insights you won't find anywhere else.... all for free. Visit: TopStartupsSummit.com
About MDI Ventures: MDI Ventures is a US$800 million+ multi-fund venture capital arm of Indonesia's largest telecom company Telkom Group. It is one of the best-performing tech investment funds in Asia. Visit: mdi.vc
Interview with the CEO of Anagram, one of the top companies recognized within the healthcare platform category.
1:04: What does Anagram do? 3:00: What’s the backstory about Anagram?
5:04: Can you explain what out-of-network care means? And what are the pain points dealing with out-of-network patients/doctors?
11:41: How do you help providers accept out-of-network benefits?
15:18: How does the payment (reimbursement) process work for patients & providers?
17:30: Why does the pricing model between patients, practices and payers fluctuate?
20:20: What the value of Anagram to out-of-network providers?
22:35: What type of providers do you normally work with?
24:26: Do patients interact with Anagram? Or is it only providers?
27:17: What scenario’s lead patients to go to out-of-network provider?
28:44: How did you collect data to predict prices/reimbursements?
30:27: What are denied claims and how do you manage them?
32:52: How accurate are you able to predict reimbursements? What happens if your prediction is wrong?
34:36: What is your implementation process?
38:00: How do you manage long sales cycles in healthcare?
39:32: What is the business model?
40:00: What is the market size for your product?
43:03: How has the pandemic affected your company?
46:32: What is the future of payments for healthcare?
48:51: Closing Remarks
About Anagram: Anagram’s platform allows providers to accept out-of-network benefits. Their platform allows providers to decide what insurance networks they’d like to accept and what prices/discounts they’d like to charge. Their platform pulls insurance benefits information digitally and manages denied claims on behalf of providers. Visit: www.anagram.care
About Top Startups Summit: The Top Startups Summit was created to recognize the top startups in a specific industries globally. We've spent months mapping industries, selecting the top companies and writing detailed reports on the best technologies. We have hosted many investor-only events to discuss industry trends. Now we're opening our work to the public. We will share the list of all the top startups per industry, a lengthy due diligence report and we'll invite the best founders & investors on stage to share unique insights you won't find anywhere else.... all for free. Visit: TopStartupsSummit.com
Interview with the CEO of Pops, one of the top companies recognized within the healthcare device category.
0:48 What does Pops do?
5:28 What’s the backstory of why you created Pops?
6:35 Why did you build the glucose meter the way you did?
8:23 How often do users have to purchase test strips for your device?
11:00 You are FDA approved? Why is this important?
13:06 Can you share details about your health management application?
15:32 How do you personalize experiences for each user?
17:03 What features resonate the most with your users?
18:12 Why did you create both a device and software to manage diabetes?
19:24 Are there any risks or limitations using Pops?
21:22 What is your business model and go-to market strategy?
23:08 How do you manage long sales cycles in healthcare?
24:44 What is the market size of managing diabetes?
26:45 How has the pandemic affected your company?
29:24 What is the future of health management?
30:48 Closing Remarks
About Pops: Pops Diabetes Care provides a FDA-cleared integrated glucose meter 2/3rds the size of an iPhone wirelessly connected to Mina, an AI-virtual coach. The meter is the only commercially released meter that does not require the user to assemble it for a test. Visit: popsdiabetes.com
About Top Startups Summit: The Top Startups Summit was created to recognize the top startups in a specific industries globally. We've spent months mapping industries, selecting the top companies and writing detailed reports on the best technologies. We have hosted many investor-only events to discuss industry trends. Now we're opening our work to the public. We will share the list of all the top startups per industry, a lengthy due diligence report and we'll invite the best founders & investors on stage to share unique insights you won't find anywhere else.... all for free. Visit: TopStartupsSummit.com
About MDI Ventures: MDI Ventures is a US$800 million+ multi-fund venture capital arm of Indonesia's largest telecom company Telkom Group. It is one of the best-performing tech investment funds in Asia. Visit: mdi.vc
Interview with Robert Garber, Partner at 7wire Ventures, one of the top investors recognized within the healthcare industry.
0:48 What is the background of 7Wire Ventures?
1:50 Who is 7Wire Ventures?
3:05 Why does your investment thesis revolve around informed connected health consumer?
7:41 Healthcare is so vast, how do you filter this industry?
12:15 You seem to focus on health management category, why?
15:05 Are you looking for moonshots or something practical as an early stage healthcare investor?
17:58 Can it be limiting to invest in healthcare?
21:40 Can you highlight some of your investments?
26:00 How do you know the right tool to manage a specific health issue?
29:08 Do you focus on platform plays or tools for specific conditions?
33:00 Healthcare has long sales cycles - how does this shape your investment thesis?
36:13 What is the business model that works for the health management category?
40:00 How does the pandemic change your outlook on healthcare?
45:13 Highlighting unique features of 7Wire Ventures: portfolio development, coalition and hatch program
51:25 Closing Remarks
About 7Wire Ventures: 7wire Ventures is an early-stage healthcare venture fund focused on innovative products and services that empower and engage consumers to become more proactive and effective with their healthcare decisions. We look for solutions that improve health outcomes, reduce costs, drive efficiency, and lead to better personal health. Visit: www.7wireventures.com
About Top Startups Summit: The Top Startups Summit was created to recognize the top startups in a specific industries globally. We've spent months mapping industries, selecting the top companies and writing detailed reports on the best technologies. We have hosted many investor-only events to discuss industry trends. Now we're opening our work to the public. We will share the list of all the top startups per industry, a lengthy due diligence report and we'll invite the best founders & investors on stage to share unique insights you won't find anywhere else.... all for free. Visit: TopStartupsSummit.com
About MDI Ventures: MDI Ventures is a US$800 million+ multi-fund venture capital arm of Indonesia's largest telecom company Telkom Group. It is one of the best-performing tech investment funds in Asia. Visit: mdi.vc
